世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

アプタマーの世界市場 2022-2026年

アプタマーの世界市場 2022-2026年


Global Aptamers Market 2022-2026

アプタマーの世界市場 2022-2026年 Technavio社はアプタマー市場をモニターしており、予測期間中に27.70%のCAGRで進行し、2022-2026年には13.1億ドルの成長が見込まれています。当レポートでは、アプタマー市場... もっと見る

　

　

出版社 出版年月 電子版価格 納期 ページ数 言語
TechNavio
テクナビオ 		2021年12月8日 US$2,500
シングルユーザーライセンス
ライセンス・価格情報
注文方法はこちら 		2営業日程度 120 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

アプタマーの世界市場 2022-2026年
Technavio社はアプタマー市場をモニターしており、予測期間中に27.70%のCAGRで進行し、2022-2026年には13.1億ドルの成長が見込まれています。当レポートでは、アプタマー市場について、全体的な分析、市場規模と予測、トレンド、成長要因、課題のほか、約25社のベンダーを網羅したベンダー分析を行っています。
本レポートでは、現在の世界市場のシナリオ、最新のトレンドとドライバー、そして市場全体の環境に関する最新の分析を提供しています。市場を牽引しているのは、がんの罹患率の増加に伴う新規診断薬の需要の高まりと、アプタマーを用いた治療薬の開発に向けた臨床試験の増加です。さらに、がんの発生率の増加が新規診断薬の需要を高めていることも、市場の成長を後押しすると予想されます。
アプタマー市場の分析には、アプリケーションセグメントと地域別の状況が含まれています。
Technavioのアプタマー市場は以下のように区分されています。
アプリケーション別
- 治療薬の開発
- 研究・開発
- 診断用
- その他
地域別構成比
- 北アメリカ
- ヨーロッパ
- アジア
- ROW
本調査では、今後数年間のアプタマー市場の成長を促進する主な理由の一つとして、抗体よりもアプタマーの方が優れているという認識の高まりを挙げています。
Technavio社は、複数の情報源から得たデータを調査、合成、主要なパラメータの分析によってまとめ、市場の詳細なイメージを提示しています。当レポートでは、アプタマー市場について以下の項目を取り上げています。
- アプタマーズ市場のサイジング
- アプタマー市場の予測
- アプタマー市場の産業分析
Technavioの堅牢なベンダー分析は、クライアントの市場での地位向上を支援することを目的としており、本レポートではこれに沿って、Aptagen LLC、Aptamer Group Ltd.、Aptamer Sciences Inc.、APTATARGETS SL、Base Pair Biotechnologies Inc.、Kaneka Corp.、Maravai LifeSciences Holdings Inc.、NeoVentures Biotechnology Inc.、SomaLogic Inc.、Vivonics Inc.など、いくつかの主要なアプタマー市場ベンダーの詳細な分析を行っています。また、アプタマー市場分析レポートには、市場成長に影響を与える今後のトレンドや課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からの情報を含む、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加えて、包括的な市場およびベンダーランドスケープが含まれています。このレポートの詳細については、- https://www.technavio.com/report/aptamers-market-industry-analysis をご覧ください。
Technavio社は、複数の情報源から得たデータを調査、合成、要約し、利益、価格、競争、プロモーションなどの主要なパラメーターを分析することで、市場の詳細なイメージを提示しています。また、業界の主要なインフルエンサーを特定することで、様々な市場の側面を提示しています。提示されたデータは包括的で信頼性が高く、一次および二次両方の広範な調査の結果です。Technavio社の市場調査レポートは、正確な市場成長を予測するために、完全な競合状況と、質的および量的調査を用いた詳細なベンダー選択方法と分析を提供しています。

ページTOPに戻る


目次

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2021
o Market outlook: Forecast for 2021 - 2026
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Therapeutics development - Market size and forecast 2021-2026
o Research and development - Market size and forecast 2021-2026
o Diagnostic - Market size and forecast 2021-2026
o Others - Market size and forecast 2021-2026
o Market opportunity by Application
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2021-2026
o Europe - Market size and forecast 2021-2026
o Asia - Market size and forecast 2021-2026
o ROW - Market size and forecast 2021-2026
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Aptagen LLC
o Aptamer Group Ltd.
o Aptamer Sciences Inc
o APTATARGETS SL
o Base Pair Biotechnologies Inc.
o Kaneka Corp.
o Maravai LifeSciences Holdings Inc.
o NeoVentures Biotechnology Inc
o SomaLogic Inc
o Vivonics Inc
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2021 - 2026 ($ million)
• 13: Global market: Year-over-year growth 2021 - 2026 (%)
• 14: Five forces analysis 2021 & 2026
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2021
• 21: Application - Market share 2021-2026 (%)
• 22: Comparison by Application
• 23: Therapeutics development - Market size and forecast 2021-2026 ($ million)
• 24: Therapeutics development - Year-over-year growth 2021-2026 (%)
• 25: Research and development - Market size and forecast 2021-2026 ($ million)
• 26: Research and development - Year-over-year growth 2021-2026 (%)
• 27: Diagnostic - Market size and forecast 2021-2026 ($ million)
• 28: Diagnostic - Year-over-year growth 2021-2026 (%)
• 29: Others - Market size and forecast 2021-2026 ($ million)
• 30: Others - Year-over-year growth 2021-2026 (%)
• 31: Market opportunity by Application
• 32: Customer landscape
• 33: Market share By Geographical Landscape 2021-2026 (%)
• 34: Geographic comparison
• 35: North America - Market size and forecast 2021-2026 ($ million)
• 36: North America - Year-over-year growth 2021-2026 (%)
• 37: Europe - Market size and forecast 2021-2026 ($ million)
• 38: Europe - Year-over-year growth 2021-2026 (%)
• 39: Asia - Market size and forecast 2021-2026 ($ million)
• 40: Asia - Year-over-year growth 2021-2026 (%)
• 41: ROW - Market size and forecast 2021-2026 ($ million)
• 42: ROW - Year-over-year growth 2021-2026 (%)
• 43: Key leading countries
• 44: Market opportunity By Geographical Landscape ($ million)
• 45: Impact of drivers and challenges
• 46: Vendor landscape
• 47: Landscape disruption
• 48: Industry risks
• 49: Vendors covered
• 50: Market positioning of vendors
• 51: Aptagen LLC - Overview
• 52: Aptagen LLC - Product and service
• 53: Aptagen LLC - Key offerings
• 54: Aptagen LLC - Key customers
• 55: Aptagen LLC - Segment focus
• 56: Aptamer Group Ltd. - Overview
• 57: Aptamer Group Ltd. - Product and service
• 58: Aptamer Group Ltd. - Key offerings
• 59: Aptamer Group Ltd. - Key customers
• 60: Aptamer Group Ltd. - Segment focus
• 61: Aptamer Sciences Inc - Overview
• 62: Aptamer Sciences Inc - Product and service
• 63: Aptamer Sciences Inc - Key offerings
• 64: Aptamer Sciences Inc - Key customers
• 65: Aptamer Sciences Inc - Segment focus
• 66: APTATARGETS SL - Overview
• 67: APTATARGETS SL - Product and service
• 68: APTATARGETS SL - Key offerings
• 69: APTATARGETS SL - Key customers
• 70: APTATARGETS SL - Segment focus
• 71: Base Pair Biotechnologies Inc. - Overview
• 72: Base Pair Biotechnologies Inc. - Product and service
• 73: Base Pair Biotechnologies Inc. - Key offerings
• 74: Base Pair Biotechnologies Inc. - Key customers
• 75: Base Pair Biotechnologies Inc. - Segment focus
• 76: Kaneka Corp. - Overview
• 77: Kaneka Corp. - Business segments
• 78: Kaneka Corp. - Key offerings
• 79: Kaneka Corp. - Key customers
• 80: Kaneka Corp. - Segment focus
• 81: Maravai LifeSciences Holdings Inc. - Overview
• 82: Maravai LifeSciences Holdings Inc. - Business segments
• 83: Maravai LifeSciences Holdings Inc. - Key offerings
• 84: Maravai LifeSciences Holdings Inc. - Key customers
• 85: Maravai LifeSciences Holdings Inc. - Segment focus
• 86: NeoVentures Biotechnology Inc - Overview
• 87: NeoVentures Biotechnology Inc - Product and service
• 88: NeoVentures Biotechnology Inc - Key offerings
• 89: NeoVentures Biotechnology Inc - Key customers
• 90: NeoVentures Biotechnology Inc - Segment focus
• 91: SomaLogic Inc - Overview
• 92: SomaLogic Inc - Product and service
• 93: SomaLogic Inc - Key offerings
• 94: SomaLogic Inc - Key customers
• 95: SomaLogic Inc - Segment focus
• 96: Vivonics Inc - Overview
• 97: Vivonics Inc - Product and service
• 98: Vivonics Inc - Key offerings
• 99: Vivonics Inc - Key customers
• 100: Vivonics Inc - Segment focus
• 101: Currency conversion rates for US$
• 102: Research Methodology
• 103: Validation techniques employed for market sizing
• 104: Information sources
• 105: List of abbreviations

　

ページTOPに戻る


　

Summary

Global Aptamers Market 2022-2026
Technavio has been monitoring the aptamers market and it is poised to grow by $ 1.31 bn during 2022-2026, progressing at a CAGR of 27.70% during the forecast period. Our report on the aptamers market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of cancer boosts demand for novel diagnostics and rising number of clinical trials to develop aptamer-based therapeutics. In addition, the increasing incidence of cancer boosts demand for novel diagnostics is anticipated to boost the growth of the market as well.
The aptamers market analysis includes the application segment and geographic landscape.
Technavio's aptamers market is segmented as below:
By Application
• Therapeutics development
• Research and development
• Diagnostic
• Others
By Geographical Landscape
• North America
• Europe
• Asia
• ROW
This study identifies the rising awareness of the advantages of aptamers over antibodiesas one of the prime reasons driving the aptamers market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on aptamers market covers the following areas:
• Aptamers market sizing
• Aptamers market forecast
• Aptamers market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading aptamers market vendors that include Aptagen LLC, Aptamer Group Ltd., Aptamer Sciences Inc, APTATARGETS SL, Base Pair Biotechnologies Inc., Kaneka Corp., Maravai LifeSciences Holdings Inc., NeoVentures Biotechnology Inc, SomaLogic Inc, and Vivonics Inc. Also, the aptamers market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/aptamers-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.



ページTOPに戻る


Table of Contents

• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2021
o Market outlook: Forecast for 2021 - 2026
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Application
o Market segments
o Comparison by Application
o Therapeutics development - Market size and forecast 2021-2026
o Research and development - Market size and forecast 2021-2026
o Diagnostic - Market size and forecast 2021-2026
o Others - Market size and forecast 2021-2026
o Market opportunity by Application
• Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2021-2026
o Europe - Market size and forecast 2021-2026
o Asia - Market size and forecast 2021-2026
o ROW - Market size and forecast 2021-2026
o Key leading countries
o Market opportunity By Geographical Landscape
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Vendor landscape
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Aptagen LLC
o Aptamer Group Ltd.
o Aptamer Sciences Inc
o APTATARGETS SL
o Base Pair Biotechnologies Inc.
o Kaneka Corp.
o Maravai LifeSciences Holdings Inc.
o NeoVentures Biotechnology Inc
o SomaLogic Inc
o Vivonics Inc
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations

Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global - Market size and forecast 2021 - 2026 ($ million)
• 13: Global market: Year-over-year growth 2021 - 2026 (%)
• 14: Five forces analysis 2021 & 2026
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition - Five forces 2021
• 21: Application - Market share 2021-2026 (%)
• 22: Comparison by Application
• 23: Therapeutics development - Market size and forecast 2021-2026 ($ million)
• 24: Therapeutics development - Year-over-year growth 2021-2026 (%)
• 25: Research and development - Market size and forecast 2021-2026 ($ million)
• 26: Research and development - Year-over-year growth 2021-2026 (%)
• 27: Diagnostic - Market size and forecast 2021-2026 ($ million)
• 28: Diagnostic - Year-over-year growth 2021-2026 (%)
• 29: Others - Market size and forecast 2021-2026 ($ million)
• 30: Others - Year-over-year growth 2021-2026 (%)
• 31: Market opportunity by Application
• 32: Customer landscape
• 33: Market share By Geographical Landscape 2021-2026 (%)
• 34: Geographic comparison
• 35: North America - Market size and forecast 2021-2026 ($ million)
• 36: North America - Year-over-year growth 2021-2026 (%)
• 37: Europe - Market size and forecast 2021-2026 ($ million)
• 38: Europe - Year-over-year growth 2021-2026 (%)
• 39: Asia - Market size and forecast 2021-2026 ($ million)
• 40: Asia - Year-over-year growth 2021-2026 (%)
• 41: ROW - Market size and forecast 2021-2026 ($ million)
• 42: ROW - Year-over-year growth 2021-2026 (%)
• 43: Key leading countries
• 44: Market opportunity By Geographical Landscape ($ million)
• 45: Impact of drivers and challenges
• 46: Vendor landscape
• 47: Landscape disruption
• 48: Industry risks
• 49: Vendors covered
• 50: Market positioning of vendors
• 51: Aptagen LLC - Overview
• 52: Aptagen LLC - Product and service
• 53: Aptagen LLC - Key offerings
• 54: Aptagen LLC - Key customers
• 55: Aptagen LLC - Segment focus
• 56: Aptamer Group Ltd. - Overview
• 57: Aptamer Group Ltd. - Product and service
• 58: Aptamer Group Ltd. - Key offerings
• 59: Aptamer Group Ltd. - Key customers
• 60: Aptamer Group Ltd. - Segment focus
• 61: Aptamer Sciences Inc - Overview
• 62: Aptamer Sciences Inc - Product and service
• 63: Aptamer Sciences Inc - Key offerings
• 64: Aptamer Sciences Inc - Key customers
• 65: Aptamer Sciences Inc - Segment focus
• 66: APTATARGETS SL - Overview
• 67: APTATARGETS SL - Product and service
• 68: APTATARGETS SL - Key offerings
• 69: APTATARGETS SL - Key customers
• 70: APTATARGETS SL - Segment focus
• 71: Base Pair Biotechnologies Inc. - Overview
• 72: Base Pair Biotechnologies Inc. - Product and service
• 73: Base Pair Biotechnologies Inc. - Key offerings
• 74: Base Pair Biotechnologies Inc. - Key customers
• 75: Base Pair Biotechnologies Inc. - Segment focus
• 76: Kaneka Corp. - Overview
• 77: Kaneka Corp. - Business segments
• 78: Kaneka Corp. - Key offerings
• 79: Kaneka Corp. - Key customers
• 80: Kaneka Corp. - Segment focus
• 81: Maravai LifeSciences Holdings Inc. - Overview
• 82: Maravai LifeSciences Holdings Inc. - Business segments
• 83: Maravai LifeSciences Holdings Inc. - Key offerings
• 84: Maravai LifeSciences Holdings Inc. - Key customers
• 85: Maravai LifeSciences Holdings Inc. - Segment focus
• 86: NeoVentures Biotechnology Inc - Overview
• 87: NeoVentures Biotechnology Inc - Product and service
• 88: NeoVentures Biotechnology Inc - Key offerings
• 89: NeoVentures Biotechnology Inc - Key customers
• 90: NeoVentures Biotechnology Inc - Segment focus
• 91: SomaLogic Inc - Overview
• 92: SomaLogic Inc - Product and service
• 93: SomaLogic Inc - Key offerings
• 94: SomaLogic Inc - Key customers
• 95: SomaLogic Inc - Segment focus
• 96: Vivonics Inc - Overview
• 97: Vivonics Inc - Product and service
• 98: Vivonics Inc - Key offerings
• 99: Vivonics Inc - Key customers
• 100: Vivonics Inc - Segment focus
• 101: Currency conversion rates for US$
• 102: Research Methodology
• 103: Validation techniques employed for market sizing
• 104: Information sources
• 105: List of abbreviations

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

TechNavio社の